Document Detail


Glutathione S-transferase catalyzed desulfonylation of a sulfonylfuropyridine.
MedLine Citation:
PMID:  19797605     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
MRL-1, a cannabinoid receptor-1 inverse agonist, was a member of a lead candidate series for the treatment of obesity. In rats, MRL-1 is eliminated mainly via metabolism, followed by excretion of the metabolites into bile. The major metabolite M1, a glutathione conjugate of MRL-1, was isolated and characterized by liquid chromatography/mass spectrometry and NMR spectroscopic methods. The data suggest that the t-butylsulfonyl group at C-2 of furopyridine was displaced by the glutathionyl group. In vitro experiments using rat and monkey liver microsomes in the presence of reduced glutathione (GSH) showed that the formation of M1 was independent of NADPH and molecular oxygen, suggesting that this reaction was not mediated by an oxidative reaction and a glutathione S-transferase (GST) was likely involved in catalyzing this reaction. Furthermore, a rat hepatic GST was capable of catalyzing the conversion of MRL-1 to M1 in the presence of GSH. When a close analog of MRL-1, a p-chlorobenzenesulfonyl furopyridine derivative (MRL-2), was incubated with rat liver microsomes in the presence of GSH, p-chlorobenzene sulfinic acid (M2) was also identified as a product in addition to the expected M1. Based on these data, a mechanism is proposed involving direct nucleophilic addition of GSH to sulfonylfuropyridine, resulting in an unstable adduct that spontaneously decomposes to form M1 and M2.
Authors:
Thomas J Bateman; John S Debenham; Christina Madsen-Duggan; Richard B Toupence; Thomas F Walsh; Quang Truong; Scott A Bradley; George A Doss; Sanjeev Kumar; Vijay Bhasker G Reddy
Related Documents :
12904275 - Effect of zn7-metallothionein on oxidative stress in liver of rats with severe thermal ...
10490505 - Glutathione conjugation of electrophilic metabolites of 1-nitronaphthalene in rat trach...
9433915 - Spaceflight downregulates antioxidant defense systems in rat liver.
11794465 - Changes in lipid peroxidation and antioxidant enzyme activities by triiodothyronine (t3...
3252025 - Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in sprague-...
20051255 - In vivo pharmacokinetics of bakuchiol after oral administration of bakuchiol extraction...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug metabolism and disposition: the biological fate of chemicals     Volume:  38     ISSN:  1521-009X     ISO Abbreviation:  Drug Metab. Dispos.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-16     Completed Date:  2010-03-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421550     Medline TA:  Drug Metab Dispos     Country:  United States    
Other Details:
Languages:  eng     Pagination:  108-14     Citation Subset:  IM    
Affiliation:
Department of Drug Metabolism and Pharmacokinetics, Merck Research Laboratories, Rahway, New Jersey, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bile / chemistry
Biocatalysis*
Biotransformation / physiology
Chromatography, Liquid
Cytosol / metabolism
Dogs
Glutathione / metabolism
Glutathione Transferase / metabolism*
Haplorhini
Humans
Liver / enzymology
Magnetic Resonance Spectroscopy
Male
Microsomes, Liver / enzymology
Molecular Structure
NADP / metabolism
Pyridines / metabolism,  pharmacokinetics*
Rats
Rats, Sprague-Dawley
Receptor, Cannabinoid, CB1 / antagonists & inhibitors
Species Specificity
Sulfur Compounds / metabolism,  pharmacokinetics*
Tandem Mass Spectrometry
Chemical
Reg. No./Substance:
0/Cnr1 protein, rat; 0/Pyridines; 0/Receptor, Cannabinoid, CB1; 0/Sulfur Compounds; 53-59-8/NADP; 70-18-8/Glutathione; EC 2.5.1.18/Glutathione Transferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases.
Next Document:  Intestinal Detoxification Limits the Activation of Hepatic PXR by Lithocholic Acid.